Evaluate Eribulin ORA in Subjects With Solid Tumors
Clinical trial NCT04013217 · TERMINATED
Trial details
- NCT number
- NCT04013217
- Sponsor
- Health Hope Pharma
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-29
- Primary completion
- 2022-03-02
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.